Welling Glenn W.

Director Welling Glenn W. buys 400,000 BRCC shares at $1.25; cluster of 4 insider buys in 14 days amid unprofitable quarter.

Glenn W. Welling, a director, purchased 400,000 shares of BRC Inc. at $1.25 on 2025-07-18, raising his holdings to 13,935,560 shares. The transaction occurs during a period of coordinated insider activity: 3 other insiders also bought within the past 14 days, suggesting aligned conviction at current valuations. However, the fundamental backdrop is material: the company posted a net loss of $-2,888,000.00 in its latest quarter, annual revenue growth is negative at -1.0%, and the company remained unprofitable over its most recent full fiscal year. At his prior BRCC transactions, Welling's timing has been mixed: 2 of his 3 prior buys at this ticker yielded positive 90-day returns (+27.5% and +19.1%), but his most recent September 2024 buy resulted in a 90-day decline of -1.9%. The stock is currently trading at $1.91, down -67.5% from its 52-week high of $5.87, which provides context for the timing of this accumulation relative to depressed levels.

Director Welling Glenn W. bought 684.5K BRCC shares at $3.17 on 2024-09-13 ($2.2M); 90d return -41.1%, reversing 2 consecutive well-timed buys at this ticker.

Director Welling Glenn W. purchased 684,542 shares at $3.17 on 2024-09-13, increasing his holdings by 5.3% to 13,535,560 shares. His two prior purchases at BRCC (on 2023-12-11 and 2023-11-15) were well-timed, each followed by positive 90-day returns of 27.5% and 19.1% respectively. However, this transaction occurred during material deterioration: the stock has declined 41.1% over the prior 90 days and is trading -46.0% from its 52-week high of $6.80. While his cross-ticker track record shows a 100% 90-day win rate with average 90-day returns of +23.3%, the company remains unprofitable (annual net income negative) despite strong revenue growth of +31.3% year-over-year. The reversal from prior well-timed execution combined with sustained operational losses and sharp recent price weakness merits close attention to fundamentals driving this renewed commitment.